AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet in the treatment of canine mast cell tumors
PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS…
TOKYO CREATIVE SALON 2026 Officially Announced
Japan's Largest Creative Festival Returns to Tokyo, March 13–22, 2026TOKYO, Feb. 5,…
AIM ImmunoTech Announces Changes to Key Dates and Terms Related to Announced Rights Offering
OCALA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE…
STARTRADER Announced as Official Partner of the Porsche Carrera Cup Middle East
DUBAI, UAE, Jan. 26, 2026 /PRNewswire/ -- STARTRADER, a leading global online…
Optivell Officially Announced as a Vision Support Formula for Preventive Eye Wellness
New York City, NY, Jan. 17, 2026 (GLOBE NEWSWIRE) -- OPTIVELL INTRODUCED…
Cycurion, Inc. (NASDAQ: CYCU) Announces Corrected Dividend Distribution Ratio of 0.0080 in Connection with its Previously Announced $500,000 Common Share Dividend
MCLEAN, Va., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU)…
Events and athlete quota for Dolomiti Valtellina 2028 announced
15 December 2025 - The International Olympic Committee (IOC) today announced the event…
Vaxil Announces Close of Previously Announced Non-Brokered Private Placement and Update on Board of Directors
December 04, 2025 07:00 ET | Source: Vaxil Bio Ltd. Not for…
First Participating Phygital Stars for the Games of the Future 2025 in Abu Dhabi Announced
Elite clubs and phygital athletes from around the world confirmed to compete…
International MICE Summit 2025 (IMS25) opening delivers global investment and events industry transformation, 20 deals announced
International MICE Summit 2025 (IMS25) opens with landmark announcements, signaling a new…
